Fmoc-Gly-Gly-Ser(Psi(Me,Me)Pro)-OH contains a pseudoproline dipeptide motif that disrupts aggregation during solid-phase synthesis. Gly-Gly provides a flexible spacer, while the Ser(Psi(Me,Me)Pro) unit transiently introduces a cyclic constraint. Researchers exploit this building block to improve difficult peptide assemblies and folding yields. Applications include SPPS optimization, aggregation-prone sequence construction, and conformational-control studies.
Fmoc-Gly-Gly-Ser(Psi(Me, Me)Pro)-OH is a synthetic peptide building block featuring a pseudoproline motif, which is widely recognized for its ability to facilitate peptide synthesis and enhance the solubility and handling of challenging peptide sequences. Incorporating Fmoc-protected glycine-glycine-serine with a Psi(Me, Me)Pro pseudoproline modification, this compound is specifically designed to address aggregation and folding issues that often arise during solid-phase peptide synthesis (SPPS). Its unique structural attributes make it an important tool for researchers engaged in advanced peptide chemistry, particularly for the assembly of long or aggregation-prone sequences where conventional amino acid derivatives may be insufficient.
Peptide synthesis optimization: Utilization of Fmoc-Gly-Gly-Ser(Psi(Me, Me)Pro)-OH is particularly valuable in improving the efficiency and fidelity of SPPS. The pseudoproline motif disrupts intra- and intermolecular hydrogen bonding, significantly reducing on-resin aggregation during chain elongation. This property enables the successful synthesis of otherwise difficult or insoluble peptides, supporting the production of high-quality peptide products for research and development purposes.
Sequence-specific folding studies: The presence of the Psi(Me, Me)Pro pseudoproline in the serine residue facilitates exploration of peptide folding and conformational dynamics. By introducing conformational constraints, this modified tripeptide can be used to investigate the effects of backbone flexibility and secondary structure formation in model peptides or protein fragments. Such studies contribute to a deeper understanding of the relationship between sequence, structure, and function in peptide science.
Aggregation suppression in peptide libraries: When constructing peptide libraries for screening or high-throughput studies, aggregation can compromise diversity and yield. Incorporation of pseudoproline-containing building blocks like this one helps minimize aggregation-related losses, ensuring more consistent library quality and greater representation of sequence variants. This application is particularly pertinent in combinatorial chemistry and early-stage drug discovery research.
Facilitating synthesis of "difficult" sequences: Many biologically relevant peptides contain glycine- and serine-rich motifs that are prone to aggregation or incomplete synthesis. Use of Fmoc-Gly-Gly-Ser(Psi(Me, Me)Pro)-OH as a strategic insertion point within these sequences enables researchers to overcome synthetic bottlenecks, allowing access to full-length peptides that might otherwise be inaccessible with standard amino acid derivatives. This is especially advantageous for the synthesis of peptides with therapeutic, diagnostic, or structural research relevance.
Analytical method development: The unique properties of this pseudoproline-containing peptide derivative also make it a useful standard or reference compound in analytical method development for peptide characterization. Its defined structure and predictable behavior in chromatographic and spectrometric analyses support validation of peptide purification, identification, and quantification protocols, thereby enhancing the reliability of analytical workflows in peptide research laboratories.
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.